mission & vision
DRIVING FORCE IN DRUG DEVELOPMENT SERVICES
Vector B2B aims to enable the discovery and development of new therapies by offering a range of comprehensive services and expertise to clients in the biotech, pharmaceutical and academic sector.
We earn our clients’ trust by offering the best services, tailored to your specific needs.
FROM BENCH TO BEDSIDe: COVERING THE WHOLE VALUE CHAIN OF PHARMACEUTICAL R&D
VectorB2B gathers the scattered capacities of the academic and industrial shareholders in the sector of health biotechnology to provide integrated services in drug discovery and screening, project design and implementation, pre-clinical and clinical scientific management, process development and contract manufacturing (GMP). The shareholders are a strong and complementary set of academic partners and biopharmaceutical companies renowned in the health sector in Portugal. Together, they form a robust asset of knowledge and innovation, particularly in the domain of biological therapeutics.
Serving biomedical R&D
VectorB2B is your partner for cost-efficient, rapid and ISO-compliant drug discovery & development.
Seamless process development from lab to GMP
Our specialists develop the best process for your needs, including galenic formulation and biologic cultures – from lab scale to bioreactor
Accelerate SARS-CoV-2 therapeutic, vaccine or test development
Let us support you in the fight against COVID-19 with our antibody development services and our clinical trial expertise